000 01171 a2200349 4500
005 20250517181807.0
008 ####s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.18215
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCurtis, Nicola J
245 0 0 _aPre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.
_h[electronic resource]
260 _bOncotarget
_cSep 2017
300 _a69219-69236 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aMooney, Lorraine
700 1 _aHopcroft, Lorna
700 1 _aMichopoulos, Filippos
700 1 _aWhalley, Nichola
700 1 _aZhong, Haihong
700 1 _aMurray, Clare
700 1 _aLogie, Armelle
700 1 _aRevill, Mitchell
700 1 _aByth, Kate F
700 1 _aBenjamin, Amanda D
700 1 _aFirth, Mike A
700 1 _aGreen, Stephen
700 1 _aSmith, Paul D
700 1 _aCritchlow, Susan E
773 0 _tOncotarget
_gvol. 8
_gno. 41
_gp. 69219-69236
856 4 0 _uhttps://doi.org/10.18632/oncotarget.18215
_zAvailable from publisher's website
999 _c27702613
_d27702613